Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy - a Subgroup Analysis of Hormone Receptor-Positive HER2-Negative Breast Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Breast Care 12.5 (2017): S. 318 - 323
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2017
- Urheber
-
Kolberg, Hans-Christian
Lövey, György
Akpolat-Basci, Leyla
Stephanou, Miltiades
Fasching, Peter Andreas
Untch, Michael
Hoffmann, Oliver
Bulsara, Max
Vaidya, Jayant S.
Kolberg-Liedtke, Cornelia
- URN
-
urn:nbn:de:bvb:29-opus4-107170
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kolberg, Hans-Christian
- Lövey, György
- Akpolat-Basci, Leyla
- Stephanou, Miltiades
- Fasching, Peter Andreas
- Untch, Michael
- Hoffmann, Oliver
- Bulsara, Max
- Vaidya, Jayant S.
- Kolberg-Liedtke, Cornelia
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2017
Ähnliche Objekte (12)
Breast diseases : breast-conserving therapy, non-invasive therapy, mastopathy
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Predictors of poor aesthetic outcome after breast-conserving surgery in patients with breast cancer
Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy?
Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
EGFR Expression in HER2-Driven Breast Cancer Cells
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: A cost estimate with real-world data
Early modulation of circulating MicroRNAs levels in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
Stromal vapors for real-time molecular guidance of breast-conserving surgery
Breast diseases : breast-conserving therapy, non-invasive therapy, mastopathy
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Predictors of poor aesthetic outcome after breast-conserving surgery in patients with breast cancer
Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy?
Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
EGFR Expression in HER2-Driven Breast Cancer Cells
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: A cost estimate with real-world data
Early modulation of circulating MicroRNAs levels in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
Stromal vapors for real-time molecular guidance of breast-conserving surgery
Breast diseases : breast-conserving therapy, non-invasive therapy, mastopathy
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Predictors of poor aesthetic outcome after breast-conserving surgery in patients with breast cancer
Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy?
Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
EGFR Expression in HER2-Driven Breast Cancer Cells
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: A cost estimate with real-world data
Early modulation of circulating MicroRNAs levels in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy